局部雌激素治疗改善了膀雌激素受体β表达在患有过度活性膀的女性患者
1Department of Urology, Qinghai University Affiliated Hospital Xining 810000, Qinghai, China.
American journal of translational research
|January 8, 2024
概括
局部雌激素治疗可以通过增加雌激素受体β (ERβ) 在膀组织中的表达来改善女性的过度活性膀 (OAB). 这项研究将雌激素治疗与托尔特罗丁进行了比较,发现雌激素改善了ERβ水平.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 妇科 妇科医生 妇科
- 药理学 药理学是指药理学的学科.
背景情况:
- 过度活跃的膀 (OAB) 是一种常见的疾病,影响了许多女性.
- 雌激素受体β (ERβ) 在膀功能中起作用.
- 在OAB患者中,局部雌激素对ERβ表达的作用尚未完全理解.
研究的目的:
- 研究局部雌激素治疗对女性OAB患者膀组织ERβ表达的影响.
- 为了比较局部雌激素与托尔特罗丁在治疗OAB时的疗效.
主要方法:
- 一项对58名女性OAB患者的回顾性研究,分为局部雌激素和托尔特罗丁组.
- 患者每天接受治疗3周,每隔1周间隔12周.
- 使用免疫组织化学测量膀组织ERβ表达;使用OAB-q SF评估OAB症状.
主要成果:
- 在12周后,两组之间OAB-q总体得分没有显著差异.
- 与雌激素 (P=0.03) 相比,托尔特罗丁显示出尿失禁的统计显著改善.
- 与托尔特罗丁相比,局部雌激素治疗导致膀组织中的ERβ表达显著增加 (P<0.05).
结论:
- 局部雌激素治疗似乎可以改善女性患者的OAB症状.
- 雌激素的治疗作用可能与膀粘膜中ERβ表达的增强有关.
- 进一步的研究是有必要的,以阐明精确的机制.
相关概念视频
Menopause
166
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
166
Drugs for Treatment of Diarrhea-Predominant IBS
177
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
177
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
166
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
166
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
262
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
262


